| 标题 |
1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:H-C. Sun; J. Fan; F. Shen; J. Zhou; T. Song; et al 出版日期:2025-11-06 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)